GlassScriptPhysician profile
Therese M Rinaldi
NPI 1548212061
$1,236.01
in general payments reported to CMS, 2019-2025
13 companies · $288 in 2025
The $288 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $40.88 · 2021: $71.64 · 2022: $199 · 2023: $435 · 2024: $201 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $924.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $924.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $415.91 | 2021-2025 | Puraply, Via Matrix, Nushield |
| Averitas Pharma INC. | $288.48 | 2023-2025 | Qutenza |
| Abbvie INC. | $114.32 | 2021-2024 | Dalvance |
| Paratek Pharmaceuticals, INC. | $66.76 | 2023-2025 | Nuzyra |
| Convatec INC. | $63.01 | 2024 | |
| Horizon Therapeutics Plc | $54.70 | 2020-2021 | |
| Nevro Corp. | $52.14 | 2023-2024 | Senza |
| Smith+Nephew, INC. | $51.08 | 2022-2024 | Bone Anchors With Arthroscopic Delivery System |
| Zimmer Biomet Holdings, INC. | $32.99 | 2024 | Stratum Foot Plating System, Gps III Platelet Concentration System, Tapestry |
| Cashflow Solutions, LLC | $31.23 | 2023 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Grt US Holding, INC. | $29.31 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $18.76 | 2025 | |
| Synergy Orthopedics, LLC | $17.32 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Therese Rinaldi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.